Xenyhexenic acid

An immediate precursor to cholesterol in the Bloch pathway of cholesterol biosynthesis reported to activate liver X receptor-target genes in both the liver of cholesterol-free mice and in cholesterol-starved macrophage foam cells in atherosclerotic

An immediate precursor to cholesterol in the Bloch pathway of cholesterol biosynthesis reported to activate liver X receptor-target genes in both the liver of cholesterol-free mice and in cholesterol-starved macrophage foam cells in atherosclerotic

Immunogen Synthetic peptide directed towards the N terminal region of human ELOVL5 Biochem/physiol Actions ELOVL5 plays a role in elongation of long-chain polyunsaturated fatty acids.ELOVL5 plays a role in elongation of long-chain

Anti-GORASP2 Golgi reassembly stacking protein 2, 25ul UN 16

General description Anti-Zyxin antibody, Mouse monoclonal (mouse IgG2a isotype) is derived from the hybridoma ZOL301 produced by the fusion of mouse myeloma cells (NS1 cells) and splenocytes from BALB/c mice immunized with a synthetic peptide

Application For preparing methyl esters of fatty acids and for transesterification of triglycerides.

Application For preparing methyl esters of fatty acids and for transesterification of triglycerides.

This product is a ''ready-to-use'' 1X diluent for Horseradish Peroxidase (HRP) conjugated primary or secondary. This buffer contains buffered saline, and proprietary reagents to stabilize and preserve Horseradish Peroxidase (HRP) conjugated primary

This product is a ''ready-to-use'' 1X diluent for Horseradish Peroxidase (HRP) conjugated primary or secondary. This buffer contains buffered saline along with proprietary reagents to stabilize and preserve Horseradish Peroxidase (HRP) conjugated

Larsucosterol (DUR-928) trimethylamine, a cholesterol metabolite, is a potent liver X receptor (LXR) antagonist. Larsucosterol trimethylamine as a potent endogenous regulator decreases lipogenesis. Larsucosterol trimethylamine inhibits the

Larsucosterol (DUR-928) trimethylamine, a cholesterol metabolite, is a potent liver X receptor (LXR) antagonist. Larsucosterol trimethylamine as a potent endogenous regulator decreases lipogenesis. Larsucosterol trimethylamine inhibits the

Larsucosterol (DUR-928) trimethylamine, a cholesterol metabolite, is a potent liver X receptor (LXR) antagonist. Larsucosterol trimethylamine as a potent endogenous regulator decreases lipogenesis. Larsucosterol trimethylamine inhibits the